Quest Diagnostics Incorporated

Stock Chart, Company Information, and Scan Results

$243.28(as of Oct 22, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Quest Diagnostics Incorporated Company Information, Fundamentals, and Technical Indicators

Stock Price$243.28
Ticker SymbolDGX
ExchangeNyse
SectorHealthcare
IndustryDiagnostics & Research
Employees46,000
CountyUSA
Market Cap$26,171.7M
EBIDTA2,266.0M
10-Day Moving Average235.59
P/E Ratio25.66
20-Day Moving Average233.59
Forward P/E Ratio19.53
50-Day Moving Average236.83
Earnings per Share9.42
200-Day Moving Average208.64
Profit Margin10.52%
RSI62.04
Shares Outstanding110.4M
ATR6.77
52-Week High247.92
Volume1,685,681
52-Week Low168.34
Most Recent Support Level223.50
Book Value7,819.0M
Most Recent Resistance Level240.75
P/B Ratio3.48
Upper Keltner248.83
P/S Ratio2.36
Lower Keltner218.34
Debt-to-Equity Ratio0.85
Next Earnings DateUnknown
Cash Surplus-1,162.0M
Next Ex-Dividend DateUnknown

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Quest Diagnostics Incorporated In Our Stock Scanner

As of Oct 22, 2026
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.